Skip to main content
Top
Published in: Clinical Rheumatology 2/2014

01-02-2014 | Original Article

Occupational exposure in patients with the antisynthetase syndrome

Authors: Ane Labirua-Iturburu, Albert Selva-O’Callaghan, Jan-Paul Zock, Ramon Orriols, Xavier Martínez-Gómez, Miquel Vilardell-Tarrés

Published in: Clinical Rheumatology | Issue 2/2014

Login to get access

Abstract

Interstitial lung disease (ILD) is common in patients with myositis and is related with the presence of antisynthetase autoantibodies (aSA). Together with other manifestations, the resulting condition is known as the antisynthetase syndrome (ASS). Contact with certain environmental and occupational agents is also associated with the development of ILD. The objective of this study was to analyze occupational exposure and associated clinical manifestations in a cohort of patients with ASS. aSA had been identified by line immunoassay and confirmed by immunoprecipitation. Serial pulmonary function tests had been carried out to assess lung function. Thirty-two ASS patients and a control group of 32 myositis patients without aSA underwent a specific questionnaire interview to evaluate their cumulative exposure to biological dust, mineral dust, and gases/fumes up to disease onset. Comparisons were done with the Fisher exact test and Mann–Whitney test. Out from 32 ASS patients (median age, 42.7 yeras; IQR 32.2–52.5), twenty-six patients had anti-Jo-1, three anti-PL-12, and three anti-PL-7. Nine had polymyositis, 15 dermatomyositis, one amyopathic dermatomyositis, and seven pure ILD without myositis. Sixteen ASS patients (50 %) and seven (22 %) myositis patients without aSA had ever been highly exposed to dust, gases, or fumes (p < 0.05). A more than 10 % improvement in forced vital capacity occurred in 61 % of highly exposed patients and 23 % of those with low/no exposure (p = 0.06) over the observation period. In conclusion, a high percentage of patients with ASS had been exposed to dusts, gases, or fumes.
Literature
2.
go back to reference Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies. What progress has been made in the past 35 years? Chest 138:1464–1474PubMedCrossRef Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies. What progress has been made in the past 35 years? Chest 138:1464–1474PubMedCrossRef
3.
go back to reference Labirua A, Lundberg IE (2010) Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol 22:633–638PubMedCrossRef Labirua A, Lundberg IE (2010) Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol 22:633–638PubMedCrossRef
4.
go back to reference Selva-O’Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martínez-Gómez X, Vilardell-Tarrés M (2006) Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 55:791–798PubMedCrossRef Selva-O’Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martínez-Gómez X, Vilardell-Tarrés M (2006) Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 55:791–798PubMedCrossRef
5.
6.
go back to reference Levine SM, Raben N, Xie D, Askin FB, Tuder R, Mullins M et al (2007) Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis. Arthritis Rheum 56:2729–2739PubMedCrossRef Levine SM, Raben N, Xie D, Askin FB, Tuder R, Mullins M et al (2007) Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis. Arthritis Rheum 56:2729–2739PubMedCrossRef
7.
go back to reference Tillie-Leblond I, Wislez M, Valeyre D, Crestani B, Rabbat A, Israel-Biet D et al (2008) Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax 63:53–59PubMedCrossRef Tillie-Leblond I, Wislez M, Valeyre D, Crestani B, Rabbat A, Israel-Biet D et al (2008) Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax 63:53–59PubMedCrossRef
8.
go back to reference Labirua-Iturburu A, Selva-O’Callaghan A et al. (2012) Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine (Baltimore) (in press) Labirua-Iturburu A, Selva-O’Callaghan A et al. (2012) Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine (Baltimore) (in press)
9.
go back to reference Serratrice J, Granel B, Pache X et al (2001) A case of polymyositis with anti-histidyl-t-RNA synthetase (Jo-1) antibody syndrome following extensive vinyl chloride exposure. Clin Rheumatol 20:379–382PubMedCrossRef Serratrice J, Granel B, Pache X et al (2001) A case of polymyositis with anti-histidyl-t-RNA synthetase (Jo-1) antibody syndrome following extensive vinyl chloride exposure. Clin Rheumatol 20:379–382PubMedCrossRef
10.
go back to reference Scott J, Johnston I, Britton J (1990) What causes fibrosing alveolitis? A case–control study of environmental exposure to dust. BMJ 301:1015–1017PubMedCrossRef Scott J, Johnston I, Britton J (1990) What causes fibrosing alveolitis? A case–control study of environmental exposure to dust. BMJ 301:1015–1017PubMedCrossRef
11.
go back to reference Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y (1994) Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med 150:670–675PubMedCrossRef Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y (1994) Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med 150:670–675PubMedCrossRef
12.
go back to reference Moya C, Anot JM, Newman-Taylor AJ (1994) Outbreak of organising pneumonia in textile printing sprayers. Lancet 344:498–452PubMedCrossRef Moya C, Anot JM, Newman-Taylor AJ (1994) Outbreak of organising pneumonia in textile printing sprayers. Lancet 344:498–452PubMedCrossRef
13.
go back to reference Hubbard L, Lewis S, Richards K, Johnston I, Britton J (1996) Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 347:284–289PubMedCrossRef Hubbard L, Lewis S, Richards K, Johnston I, Britton J (1996) Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 347:284–289PubMedCrossRef
14.
go back to reference Baumgartner KB, Samet JM et.al. (1997) Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case control study. Am J Epidemiol 145: s61 Baumgartner KB, Samet JM et.al. (1997) Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case control study. Am J Epidemiol 145: s61
15.
go back to reference Hubbard R, Cooper M, Antoniak M et al (2000) Risk of cryptogenic fibrosing alveolitis in metal workers. Lancet 355:466–467PubMed Hubbard R, Cooper M, Antoniak M et al (2000) Risk of cryptogenic fibrosing alveolitis in metal workers. Lancet 355:466–467PubMed
16.
go back to reference Hubbard R (2001) Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis. Eur Respir J 18(Suppl 32):119s–121s Hubbard R (2001) Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis. Eur Respir J 18(Suppl 32):119s–121s
17.
18.
go back to reference Sontheimer RD (1999) Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol 11:475–482PubMedCrossRef Sontheimer RD (1999) Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol 11:475–482PubMedCrossRef
19.
go back to reference Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 16:5–40 Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 16:5–40
20.
go back to reference Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, Rodriguez-Roisin R et al (1986) Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 22:217–224PubMed Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, Rodriguez-Roisin R et al (1986) Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 22:217–224PubMed
21.
go back to reference Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824PubMedCrossRef Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824PubMedCrossRef
22.
go back to reference Ghirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, Zampieri S et al (2010) Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 49:2370–2374CrossRef Ghirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, Zampieri S et al (2010) Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 49:2370–2374CrossRef
23.
go back to reference International Labour Office (1991) International Standard Classification of Occupations: ISCO 88. ILO: Geneva International Labour Office (1991) International Standard Classification of Occupations: ISCO 88. ILO: Geneva
24.
go back to reference Matheson MC, Benke G, Raven J, Sim MR, Kromhout H, Vermeulen R, Johns DP, Walters EH, Abramson MJ (2005) Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax 60:645–651PubMedCrossRef Matheson MC, Benke G, Raven J, Sim MR, Kromhout H, Vermeulen R, Johns DP, Walters EH, Abramson MJ (2005) Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax 60:645–651PubMedCrossRef
25.
go back to reference Sunyer J, Zock JP, Kromhout H, Garcia-Esteban R, Radon K, Jarvis D, Toren K, Künzli N, Norbäck D, d’Errico A, Urrutia I, Payo F, Olivieri M, Villani S, van Sprundel M, Antó JM, Kogevinas M (2005) Lung function decline, chronic bronchitis and occupational exposures in young adults. Am J Respir Crit Care Med 172:1139–1145PubMedCrossRef Sunyer J, Zock JP, Kromhout H, Garcia-Esteban R, Radon K, Jarvis D, Toren K, Künzli N, Norbäck D, d’Errico A, Urrutia I, Payo F, Olivieri M, Villani S, van Sprundel M, Antó JM, Kogevinas M (2005) Lung function decline, chronic bronchitis and occupational exposures in young adults. Am J Respir Crit Care Med 172:1139–1145PubMedCrossRef
26.
go back to reference Miller FW, Hess EV, Clauw DJ et al (2000) Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 43:343–349 Miller FW, Hess EV, Clauw DJ et al (2000) Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 43:343–349
27.
28.
go back to reference Selva-O’Callaghan A, Tura JM, Grau-Junyent JM, Labrador-Horrillo M, Solans-Laque R, Vilardell-Tarrés M (2004) Silicone gel filled breast implants and dermatomyositis. Clin Exp Rheumatol 22:376PubMed Selva-O’Callaghan A, Tura JM, Grau-Junyent JM, Labrador-Horrillo M, Solans-Laque R, Vilardell-Tarrés M (2004) Silicone gel filled breast implants and dermatomyositis. Clin Exp Rheumatol 22:376PubMed
29.
go back to reference Slimani S, Ben Ammar A, Ladjouze-Rezig A (2010) Connective tissue diseases after heavy exposure to silica: a report of nine cases in stonemasons. Clin Rheumatol 29:531–533PubMedCrossRef Slimani S, Ben Ammar A, Ladjouze-Rezig A (2010) Connective tissue diseases after heavy exposure to silica: a report of nine cases in stonemasons. Clin Rheumatol 29:531–533PubMedCrossRef
30.
go back to reference Sanchez-Roman J, Wichmann I, Salaberri J, Varela JM, Nuñez-Roldan A (1993) Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 52:534–538PubMedCrossRef Sanchez-Roman J, Wichmann I, Salaberri J, Varela JM, Nuñez-Roldan A (1993) Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 52:534–538PubMedCrossRef
31.
go back to reference Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E, Kapitány A, Gyetvai A, Ekholm L, Novota P, Remakova M, Charles P, McHugh NJ, Padyukov L, Alfredsson L, Vencovsky J, Lundberg IE, Danko K, Ollier WE, Cooper RG (2012) Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis 71:961–965PubMedCentralPubMedCrossRef Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E, Kapitány A, Gyetvai A, Ekholm L, Novota P, Remakova M, Charles P, McHugh NJ, Padyukov L, Alfredsson L, Vencovsky J, Lundberg IE, Danko K, Ollier WE, Cooper RG (2012) Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis 71:961–965PubMedCentralPubMedCrossRef
32.
go back to reference Zock JP, Cavallé N, Kromhout H, Kennedy SM, Sunyer J, Jaén A, Muniozguren N, Payo F, Almar E, Sánchez JL, Antó JM, Kogevinas M (2004) Evaluation of specific occupational asthma risks in a community-based study with special reference to single and multiple exposures. J Expo Anal Environ Epidemiol 14:397–403PubMedCrossRef Zock JP, Cavallé N, Kromhout H, Kennedy SM, Sunyer J, Jaén A, Muniozguren N, Payo F, Almar E, Sánchez JL, Antó JM, Kogevinas M (2004) Evaluation of specific occupational asthma risks in a community-based study with special reference to single and multiple exposures. J Expo Anal Environ Epidemiol 14:397–403PubMedCrossRef
33.
go back to reference Sunyer J, Kogevinas M, Kromhout H, Antó JM, Roca J, Tobias A, Vermeulen R, Payo F, Maldonado JA, Martinez-Moratalla J, Muniozguren N (1998) Pulmonary ventilatory defects and occupational exposures in a population-based study in Spain. Am J Respir Crit Care Med 157:512–517PubMedCrossRef Sunyer J, Kogevinas M, Kromhout H, Antó JM, Roca J, Tobias A, Vermeulen R, Payo F, Maldonado JA, Martinez-Moratalla J, Muniozguren N (1998) Pulmonary ventilatory defects and occupational exposures in a population-based study in Spain. Am J Respir Crit Care Med 157:512–517PubMedCrossRef
Metadata
Title
Occupational exposure in patients with the antisynthetase syndrome
Authors
Ane Labirua-Iturburu
Albert Selva-O’Callaghan
Jan-Paul Zock
Ramon Orriols
Xavier Martínez-Gómez
Miquel Vilardell-Tarrés
Publication date
01-02-2014
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 2/2014
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2467-0

Other articles of this Issue 2/2014

Clinical Rheumatology 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.